drugset / Trial / NCT00087282

Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer

NCT00087282

Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as irinotecan and flavopiridol, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving irinotecan together with flavopiridol works in treating patients with advanced liver cancer.

Timeline

Start
2004-06
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule Intravenous
Subject alvocidib Small molecule Intravenous

Indications